What is the recommended treatment for Rhodococcus equi in foals?

Study for the Program for the Assessment of Veterinary Education (PAVE) Exam. Prepare with flashcards and multiple choice questions, each question has hints and explanations. Get ready for your exam!

Multiple Choice

What is the recommended treatment for Rhodococcus equi in foals?

Explanation:
Rhodococcus equi lives inside macrophages in the lungs of foals, so the treatment must reach those intracellular reservoirs. A macrolide like erythromycin concentrates inside these cells and lung tissue, and rifampin penetrates macrophages well and hinders RNA synthesis in the bacteria. Together, they work synergistically to achieve meaningful intracellular killing, which is essential for clearing R. equi infections. This combination is the standard approach for foals with R. equi pneumonia because it tackles the bacteria where it hides, rather than relying on an antibiotic that acts mainly outside cells. Penicillin G given alone is not ideal because it targets extracellular bacteria and doesn’t effectively reach the intracellular niche where R. equi resides. Other options like trimethoprim-sulfamethoxazole or chloramphenicol have drawbacks—variable activity against this organism or notable toxicity—making them less reliable as primary therapy. So, the erythromycin and rifampin combo best aligns with the pathogen’s intracellular lifestyle and provides the most consistent chance of clinical improvement.

Rhodococcus equi lives inside macrophages in the lungs of foals, so the treatment must reach those intracellular reservoirs. A macrolide like erythromycin concentrates inside these cells and lung tissue, and rifampin penetrates macrophages well and hinders RNA synthesis in the bacteria. Together, they work synergistically to achieve meaningful intracellular killing, which is essential for clearing R. equi infections. This combination is the standard approach for foals with R. equi pneumonia because it tackles the bacteria where it hides, rather than relying on an antibiotic that acts mainly outside cells.

Penicillin G given alone is not ideal because it targets extracellular bacteria and doesn’t effectively reach the intracellular niche where R. equi resides. Other options like trimethoprim-sulfamethoxazole or chloramphenicol have drawbacks—variable activity against this organism or notable toxicity—making them less reliable as primary therapy. So, the erythromycin and rifampin combo best aligns with the pathogen’s intracellular lifestyle and provides the most consistent chance of clinical improvement.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy